Australia markets close in 2 hours 11 minutes

Aequus Pharmaceuticals Inc (AEQ.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
0.00000.0000 (-100.00%)
At close: 12:20PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
215.2
254.896
1,380
2,715
2,593
Cost of revenue
89.834
111.234
103.559
42.779
0
Gross profit
125.366
143.662
1,276
2,672
2,593
Operating expenses
Research development
99.919
301.28
168.714
296.848
54.608
Selling general and administrative
2,605
2,525
3,476
3,614
2,872
Total operating expenses
2,841
2,964
3,774
4,039
3,119
Operating income or loss
-2,716
-2,820
-2,498
-1,367
-526.104
Interest expense
168.029
145.182
214.008
454.84
519.593
Total other income/expenses net
-2.97
-3.389
-522.708
-0.482
-4.197
Income before tax
-2,882
-2,965
-3,210
-1,810
-1,045
Income from continuing operations
-2,882
-2,965
-3,210
-1,810
-1,045
Net income
-2,882
-2,965
-3,210
-1,810
-1,045
Net income available to common shareholders
-2,882
-2,965
-3,210
-1,810
-1,045
Basic EPS
-0.02
-0.02
-0.02
-0.01
-0.01
Diluted EPS
-0.02
-0.02
-0.02
-0.01
-0.01
Basic average shares
132,874
132,634
132,634
128,850
93,181
Diluted average shares
132,874
132,634
132,634
128,850
93,181